James Saccaro's most recent trade in GE HealthCare Technologies Inc was a trade of 9,712 Common Stock, par value $0.01 per share done at an average price of $70.5 . Disclosure was reported to the exchange on June 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.54 per share. | 01 Jun 2025 | 9,712 | 61,832 | - | 70.5 | 685,084 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 32,252 | 32,252 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 11,278 | 71,544 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.30 per share. | 01 Feb 2025 | 934 | 60,266 | - | 88.3 | 82,472 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.82 per share. | 01 Sep 2024 | 1,740 | 61,200 | - | 84.8 | 147,587 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.00 per share. | 01 Jun 2024 | 8,998 | 62,940 | - | 78 | 701,844 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 29,141 | 29,141 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 10,245 | 71,938 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 54,472 | 54,472 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 43,843 | 43,843 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 36,176 | 36,176 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 11,900 | 55,743 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | James K. Saccaro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,950 | 61,693 | - | 0 | Common Stock, par value $0.01 per share | |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.62 per share. | 02 Mar 2023 | 1,061 | 177,899 (0%) | 0% | 39.6 | 42,037 | Common Stock, $1 par value |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 92,109 | 92,109 | - | - | Stock Option (Right to Buy) | |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 22,217 | 178,961 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,362 | 157,803 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.50 per share. | 13 Feb 2023 | 1,059 | 156,744 (0%) | 0% | 40.5 | 42,890 | Common Stock, $1 par value |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 49,613 | 49,613 | - | - | Stock Option (Right to Buy) | |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 10,702 | 154,276 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 7,534 | 148,381 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.75 per share. | 10 Feb 2022 | 4,807 | 143,574 (0%) | 0% | 87.7 | 421,814 | Common Stock, $1 par value |
| Baxter International | James K. Saccaro | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 2,607 | 140,847 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | James K. Saccaro | Executive VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.60 per share. | 01 Sep 2021 | 34,678 | 138,240 (0%) | 0% | 77.6 | 2,691,013 | Common Stock, $1 par value |
| Baxter International | James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 82,369 | 82,369 | - | - | Stock Option (Right to Buy) | |
| Baxter International | James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 5,241 | 175,587 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | James K. Saccaro | Executive VP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.80 per share. | 16 Feb 2021 | 4,308 | 171,279 (0%) | 0% | 77.8 | 335,162 | Common Stock, $1 par value |
| Baxter International | James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,432 | 170,346 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | James K. Saccaro | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,179 | 172,458 (0%) | 0% | 0 | Common Stock, $1 par value |